|
Aug 6
|
Nxera debuts an obesity pipeline; BridgeBio battles Alnylam for market share
|
|
Aug 5
|
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
|
|
Jul 15
|
Centessa Pharmaceuticals Advances Neurological Drug ORX142 to Clinical Trials
|
|
Apr 1
|
Nxera Pharma Announces Appointments to its Executive Leadership Team
|
|
Feb 14
|
Nxera Pharma Proposes Changes to its Board of Directors
|
|
Feb 14
|
Nxera Pharma Operational Highlights and Consolidated Results for the Fourth Quarter and Full Year 2024
|